Problem statement: Answer the MCQ question.
Question: Which drug exhibits a 6.213% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) Cc1nc(SCC(=O)NC2CC2)c2c(C)c(C)sc2n1
b.) COc1ccc(CNc2cccc3[nH]c(C(F)(F)F)nc23)cc1OC.Cl
c.) COc1ccc(OC)c(/C=N/OC(=O)Nc2ccc(Cl)cc2)c1
d.) CCCN(CC(=O)Nc1ccccc1C)C(=O)CSc1ccccc1C
e.) Cc1ccc(S(=O)(=O)N(C)Cc2cc3ccccc3[nH]c2=O)cc1
Answer: a. Cc1nc(SCC(=O)NC2CC2)c2c(C)c(C)sc2n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nc(SCC(=O)NC2CC2)c2c(C)c(C)sc2n1
Cc1nc(SCC(=O)NC2CC2)c2c(C)c(C)sc2n1
N-cyclopropyl-2-(2,5,6-trimethylthieno[2,3-d]pyrimidin-4-yl)sulfanylacetamide